Population pharmacokinetics of haloperidol in terminally ill adult patients

PURPOSE: Over 80% of the terminally ill patients experience delirium in their final days. In the treatment of delirium, haloperidol is the drug of choice. Very little is known about the pharmacokinetics of haloperidol in this patient population. We therefore designed a population pharmacokinetic stu...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Eur J Clin Pharmacol
Hlavní autoři: Franken, L. G., Mathot, R. A. A., Masman, A. D., Baar, F. P. M., Tibboel, D., van Gelder, T., Koch, B. C. P., de Winter, B. C. M.
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Berlin Heidelberg 2017
Témata:
Pharmacokinetics and Disposition
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5599451/
https://ncbi.nlm.nih.gov/pubmed/28681176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00228-017-2283-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky